06

October 6, 2014

Regenerative Stem cell therapy for Myocardial Infarction: HBXIP improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 7/October/2014, 4.41 am

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others. On […]
October 6, 2014

MiRNA-based Regenerative therapy for DM: MiRNA-503 promotes reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 7/October/2014, 15.30, 4.26 am

A recent study from the Mammalian Genetics Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories, London, United Kingdom; and School of Medicine, King’s College London, […]
October 6, 2014

Molecular therapy for Human Leukemias: Campothecin (CPT) suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 6/October/2014, 13.10

The 1975 Nobel laureate in Physiology/Medicine Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the July 8, 2014 Blood that: “Dual mechanisms by which MiR-125b represses IRF4 to induce myeloid […]
October 6, 2014

Insights into the treatment of Th2-mediated inflammation and allergic diseases: 17α-E2 (an estrogen derivative) alleviates Th2-medited inflammation and Allergy via up regulation of its target gene., 06/October/2014, 10.10 am

A study from the University of California, Los Angeles; California Institute of Technology, Pasadena; Medical Research Council; and National Institute for Medical Research, London has reported that “Transcriptomics identified a […]